NEW YORK (GenomeWeb News) – Precision BioSciences said today that it is suing Lonza Group and a number of its affiliates for patent infringement.

The lawsuit, filed in the US District Court for the District of Delaware, alleges that Switzerland-based Lonza's import and sale of its GS Xceed Gene Expression System and CHOK1SV knock-out cell line in the US infringes US Patent No. 8,377,674, which applies to Precision Bio's Directed Nuclease Editor genome editing technology.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers have sequenced the northern white rhinoceros to gauge whether it could be brought back from the edge of extinction, the New York Times reports.

Tufts University researchers found a role for miRNA in transmitting stress between generations, the Economist reports.

Bavaria expands its forensic genetic analyses to include DNA phenotyping, raising discrimination concerns.

In Science this week: gut microbiome influences liver cancer growth, spread; and more.